Multiple mechanisms of CB1 cannabinoid receptors regulation

Brain Research

Volumn 980, Issue 2, 2003, Pages 197-205

  Keren, Ora ^a   Sarne, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cannabinoid receptors; Caveolae; Clathrin coated pits; Downregulation; Endocytosis

Indexed keywords

CANNABINOID 1 RECEPTOR; CLATHRIN; OPIATE;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL DISRUPTION; CELL LINE; CELL MEMBRANE; COATED PIT; COATED VESICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

EID: 0037966246     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02970-6     Document Type: Article

References (37)

1. Abood M.E., Ditto K.E., Noel M.A., Showalter V.M., Tao Q. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. Biochem. Pharmacol. 53:1997;207-214.
2. Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem. 73:1999;2447-2459.
3. Coutts A.A., Anavi-Goffer S., Ross R.A., MacEwan D.J., Mackie K., Pertwee R.G., Irving A.J. Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J. Neurosci. 21:2001;2425-2433.
4. Damke H., Baba T., van der Bliek A.M., Schmid S.L. Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J. Cell Biol. 131:1995;69-80.
5. Fan F., Tao Q., Abood M., Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706:1996;13-20.
6. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:2001;1-24.
7. Feron O., Smith T.W., Michel T., Kelly R.A. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol Chem. 272:1997;17744-17748.
8. Heuser J.E., Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108:1989;389-400.
9. Hsieh C., Brown S., Derleth C., Mackie K. Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73:1999;493-501.
10. Jockers R., Angers S., Da Silva A., Benaroch P., Strosberg A.D., Bouvier M., Marullo S. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. J. Biol. Chem. 274:1999;28900-28908.
11. Koenig J.A., Edwardson J.M. Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol. Pharmacol. 49:1996;351-359.
12. Kojro E., Fahrenholz F. Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J. Biol. Chem. 270:1995;6476-6481.
13. Lamaze C., Schmid S.L. The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7:1995;573-580.
14. Law P.Y., Herz A., Loh H.H. Demonstration and characterization of a stereospecific opiate receptor in the neuroblastoma N18TG2 cells. J. Neurochem. 33:1979;1177-1187.
15. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
16. McIntosh H.H., Song C., Howlett A.C. CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. Mol. Brain Res. 53:1998;163-173.
17. Okamoto Y., Ninomiya H., Miwa S., Masaki T. Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J. Biol. Chem. 275:2000;6439-6446.
18. Orlandi P.A., Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141:1998;905-915.
19. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 616:1993;293-302.
20. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Natl. Rev. Mol. Cell. Biol. 3:2002;639-650.
21. Raposo G., Dunia I., Delavier-Klutchko C., Kaveri S., Strosberg A.D., Benedetti E.L. Internalization of beta-adrenergic receptors in A431 cells involves non-coated vesicles. Eur. J. Cell Biol. 50:1989;340-352.
22. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54:2002;431-467.
23. Rinaldi-Carmona M., Le Duigou A., Oustric D., Barth F., Bouaboula M., Carayon P., Casellas P., Le Fur G. Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. J. Pharmacol. Exp. Ther. 287:1998;1038-1047.
24. Rodal S.K., Skretting G., Garred O., Vilhardt F., van Deurs B., Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell. 10:1999;961-974.
25. Rodriguez de Fonseca F., Gorriti M.A., Fernandez-Ruiz J.J., Palomo T., Ramos J.A. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol. Biochem. Behav. 47:1994;33-40.
26. Roettger B.F., Rentsch R.U., Pinon D., Holicky E., Hadac E., Larkin J.M., Miller L.J. Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol. 128:1995;1029-1041.
27. Rubino T., Vigano D., Massi P., Parolaro D. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J. Neurochem. 75:2000;2080-2086.
28. Rybin V.O., Xu X., Lisanti M.P., Steinberg S.F. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275:2000;41447-41457.
29. Sabourin T., Bastien L., Bachvarov D.R., Marceau F. Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts. Mol. Pharmacol. 61:2002;546-553.
30. Shapira M., Gafni M., Sarne Y. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells. Brain Res. 806:1998;26-35.
31. Shapira M., Gafni M., Sarne Y. Long-term interactions between opioid and cannabinoid agonist at the cellular level: cross-desensitization and down-regulation. Brain Res. 960:2003;190-200.
32. Shapira M., Keren O., Gafni M., Sarne Y. Divers pathways mediate delta-opioid receptor down regulation within the same cell. Mol. Brain Res. 96:2001;142-150.
33. Shapira M., Vogel Z., Sarne Y. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell. Mol. Neurobiol. 20:2000;291-304.
34. Sorkin A., Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Natl. Rev. Mol. Cell. Biol. 3:2002;600-614.
35. Tsao P., Cao T., von Zastrow M. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol. Sci. 22:2001;91-96.
36. Ushio-Fukai M., Hilenski L., Santanam N., Becker P.L., Ma Y., Griendling K.K., Alexander R.W. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J. Biol. Chem. 276:2001;48269-48275.
37. Vickery R.G., von Zastrow M. Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J. Cell Biol. 144:1999;31-43.